Trial Profile

Randomized, Parallel, Placebo-controlled study, to assess the safety, tolerability, and efficacy of PH Gastrilex (Amorphous calcium carbonate (ACC)) in the treatment of adult subjects with moderate to severe Crohn's Disease (Israeli Ministry of health study number: MOH_2023-05-01_012591).

Status: Recruiting

Phase of Trial: Phase II

Latest Information Update: 13 Nov 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

13 Nov 2025 New trial record
30 Sep 2025 According to Amorphical Media Release, additional insights from this trial are expected as the data becomes unblinded in November and long-term follow-up progresses.
30 Sep 2025 According to Amorphical Media Release, this ongoing study has enrolled 22 patients, 17 of whom have open-label data available.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com